Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Takashi Hirama, Sarah K. Brode, Jenifer Beswick, Arjun D. Law, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Auro Viswabandya, Jeffrey H. Lipton, Hans A. Messner, Dennis (Dong Hwan) Kim, Theodore K. Marras. Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant. Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation Source: Eur Respir J 2016; 48: 1807-1810 Year: 2016 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Pulmonary function in very long-term survivors after allogeneic stem cell transplantation (aSCT) Source: International Congress 2018 – New insights in testing lung and respiratory muscle functions Year: 2018 Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017 Year: 2018 Comparison of pulmonary and extra pulmonary characteristics in allogeneic hematopoietic stem cell transplantation recipients with healthy controls Source: International Congress 2014 – Physiotherapy assessment and techniques in respiratory and non-respiratory conditions Year: 2014 Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study. Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised Year: 2021 Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Early lung function alterations after allogeneic hematopoietic stem cell transplantation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008 Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008 Mycobacterial infection caused by mycobacterium avium in allogenic bone marrow transplant (BMT) recipient with concomittant bronchiolitis obliterans as a manifestation of graft versus host disease (GvHD) Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016